The British journal of psychiatry : the journal of mental science
-
Randomized Controlled Trial Multicenter Study
Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder.
Pregabalin is a novel compound that has been shown to have efficacy in the treatment of generalised anxiety disorder and is licensed for the treatment of the disorder in the European Union. ⋯ Pregabalin, in doses of 150-600 mg/day, was a safe and effective treatment of generalised anxiety disorder in patients 65 years and older. The anxiolytic efficacy of pregabalin had an early onset (by 2 weeks) and significantly improved both psychic and somatic symptoms of anxiety.